Refrences
  1. American Cancer Society: Cancer Facts and Figures 2021. American Cancer Society, 2021. Available onlineExit Disclaimer. Last accessed June 02, 2021.
  2. Albores-Saavedra J, Gersell D, Gilks CB, Henson DE, Lindberg G, Santiago H, Scully RE, Silva E, Sobin LH, Tavassoli FJ, Travis WD, Woodruff JM. Terminology of endocrine tumors of the uterine cervix: results of a workshop sponsored by the College of American Pathologists and the National Cancer Institute. Arch Pathol Lab Med. 1997; 121:34–39.
  3. Satoh T, Takei Y, Treilleux I, Devouassoux-Shisheboran M, Ledermann J, Viswanathan AN, Mahner S, Provencher DM, Mileshkin L, Åvall-Lundqvist E, Pautier P, Reed NS, Fujiwara K. Gynecologic Cancer InterGroup (GCIG) consensus review for small cell carcinoma of the cervix. Int J Gynecol Cancer. 2014 (Suppl 3); 24:S102–08.
  4. Gardner GJ, Reidy-Lagunes D, Gehrig PA. Neuroendocrine tumors of the gynecologic tract: A Society of Gynecologic Oncology (SGO) clinical document. Gynecol Oncol. 2011; 122:190–98.
  5. Sheets EE, Berman ML, Hrountas CK, et al. Surgically treated, earlystage
neuroendocrine small-cell cervical carcinoma. Obstet Gynecol. 1988;71:10–14.
Silva EG, Kott MM, Ordonez NG. Endocrine carcinoma intermediate
cell type of the uterine cervix. Cancer. 1984;54:1705–1713.
  1. Zivanovic O, Leitao MM Jr, Park KJ, Zhao H, Diaz JP, Konner J, Alektiar K, Chi DS, Abu-Rustum NR, Aghajanian C. Small cell neuroendocrine carcinoma of the cervix: analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy. Gynecol Oncol. 2009; 112:590–93.
  2. Hoskins PJ, Swenerton KD, Pike JA, Lim P, Aquino-Parsons C, Wong F, Lee N. Small-cell carcinoma of the cervix: fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy. J Clin Oncol. 2003; 21:3495–501.
  3. Zhang Q, Xiong Y, Ye J, Zhang L, Li L. Influence of clinicopathological characteristics and comprehensive treatment models on the prognosis of small cell carcinoma of the cervix: A systematic review and meta-analysis. PloS one. 2018 Apr 11;13(4):e0192784.
  4. Galanis E, Frytak S, Lloyd RV. Extrapulmonary small cell carcinoma.Cancer 1997;79:1729–36.
  5. Satoh T, Takei Y, Treilleux I, et al. Gynecologic Cancer InterGroup (GCIG) consensus review for small cell carcinoma of the cervix. Int J Gynecol Cancer 2014;24(9 Suppl 3):S102–S108.
  6. Lo Re G, Canzonieri V, Veronesi A, Dal Bo V, Barzan L, Zancanaro C, et al. Extrapulmonary small cell carcinoma: a single-institution experience and review of the literature. Ann Oncol 1994;5:909–13.
  7. Wong YN, Jack RH, Mak V, Henrik M, Davies EA. The epidemiology and survival of extrapulmonary small cell carcinoma in South East England, 1970–2004. BMC cancer. 2009 Dec;9(1):1-7.
  8. Kim JH, Lee SH, Park J, Kim HY, Lee SI, Nam EM, Park JO, Kim K, Jung CW, Im YH, Kang WK. Extrapulmonary small-cell carcinoma: a single-institution experience. Japanese Journal of Clinical Oncology. 2004 May 1;34(5):250-4.
  9. Cohen JG, Kapp DS, Shin JY, Urban R, Sherman AE, Chen LM, Osann K, Chan JK. Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients. American journal of obstetrics and gynecology. 2010 Oct 1;203(4):347-e1.
  10. Chen J, Macdonald OK, Gaffney DK. Incidence, mortality, and prognostic factors of small cell carcinoma of the cervix. Obstetrics & Gynecology. 2008 Jun 1;111(6):1394-402.
  11. Li X, Yang R, Jia Y, Zhou J, Ma D, Li S. Prognostic risk factors for small cell carcinoma of the cervix and impact of platinum‐based neoadjuvant chemotherapy. International Journal of Gynecology & Obstetrics. 2015 Jul;130(1):31-5.
  12. Chan JK, Loizzi V, Burger RA, Rutgers J, Monk BJ. Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis. Cancer: Interdisciplinary International Journal of the American Cancer Society. 2003 Feb 1;97(3):568-74.
  13. Roy S, Ko JJ, Bahl G. Small cell carcinoma of cervix: A population-based study evaluating standardized provincial treatment protocols. Gynecologic oncology reports. 2019 Feb 1;27:54-9.
  14. Lee SW, Nam JH, Kim DY, Kim JH, Kim KR, Kim YM, Kim YT. Unfavorable prognosis of small cell neuroendocrine carcinoma of the uterine cervix: a retrospective matched case-control study. International Journal of Gynecologic Cancer. 2010 Apr 1;20(3).
  15. Castle PE, Pierz A, Stoler MH. A systematic review and meta-analysis on the attribution of human papillomavirus (HPV) in neuroendocrine cancers of the cervix. Gynecologic oncology. 2018 Feb 1;148(2):422-9.
  16. Viswanathan AN, Deavers MT, Jhingran A, Ramirez PT, Levenback C, Eifel PJ. Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence. Gynecologic oncology. 2004 Apr 1;93(1):27-33.
  17. Gardner GJ, Reidy-Lagunes D, Gehrig PA. Neuroendocrine tumors of the gynecologic tract: A Society of Gynecologic Oncology (SGO) clinical document. Gynecol Oncol 2011; 122:190.
  18. Tempfer CB, Tischoff I, Dogan A, Hilal Z, Schultheis B, Kern P, Rezniczek GA. Neuroendocrine carcinoma of the cervix: a systematic review of the literature. BMC cancer. 2018 Dec;18(1):1-6.
  19. Brennan SM, Gregory DL, Stillie A, Herschtal A, Mac Manus M, Ball DL. Should extrapulmonary small cell cancer be managed like small cell lung cancer?. Cancer: Interdisciplinary International Journal of the American Cancer Society. 2010 Feb 15;116(4):888-95.